NCT02564796: A trial that was reported late by University of California, San Diego
This trial has reported, although it was 126 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02564796 |
|---|---|
| Title | Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic Congenital Heart Disease - A Prospective Randomized Control Trial |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Nov. 30, 2016 |
| Completion date | June 30, 2020 |
| Required reporting date | June 30, 2021, midnight |
| Actual reporting date | Nov. 3, 2021 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | 126 |